Assignity Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Other Publishers | Other Information Services | Computer Systems Design and Related Services | Administrative Management and General Management Consulting Services | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Professional, Scientific, and Technical Services | All Other Support Services | All Other Miscellaneous Schools and Instruction

Full name: Assignity Sp. z o.o.

Profile Updated: August 08, 2025

Assignity is a life science consulting firm that specializes in Health Economics and Outcomes Research (HEOR) and Pricing, Reimbursement, and Market Access (PRMA). Assignity offers support for executing projects and specific components within these areas.

Headquarters
Ul. Wadowicka 8A
Krakow; Malopolskie; Postal Code: 30-415

Contact Details: Purchase the Assignity Sp. z o.o. report to view the information.

Basic Information

Total Employees:

Purchase the Assignity Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Assignity Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Assignity Sp. z o.o. report to view the information.

Incorporation Date:

July 14, 2022

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Assignity Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

95.8%▲

Total Operating Revenue

95.17%▲

Operating Profit

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

179.66%▲

Total Equity

506.88%▲

Operating Profit Margin

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Quick Ratio

1.6%▲

Similar companies